Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1970 Jan;35(1):44-50.

Lactation and genital involution effects of a new low-dose oral contraceptive on breast-feeding mothers and their infants

  • PMID: 5409834

Lactation and genital involution effects of a new low-dose oral contraceptive on breast-feeding mothers and their infants

G H Miller et al. Obstet Gynecol. 1970 Jan.

Abstract

PIP: Because of confusing experimental evidence on the effect of oral contraceptives on lactation, a new experiment administering a combination of norethindrone 1 mg with mestranol 0.08 mg or a placebo labelled as this contraceptive to 50 nursing mothers (Group I) was conducted in 1967 to try and obtain conclusive results. 50 other nursing patients (Group II) were used as controls. Quantity and quality of breast milk was determined by daily measurements of baby weight gain, supplemental feedings, and length of lactation. Baby weight gain in Group I mothers using the contraceptives was significantly lower than the control group, despite increase in supplemental calories given to the infants. The duration of lactation was also decreased significantly. This effect was more pronounced in primiparas when compared with those with previous lactation success. Involution of infant breast tissue and maternal genitals were examined and revealed no apparent effects from the contraceptive treatment. Oral contraceptives appear to be contraindicated in lactating mothers.

PubMed Disclaimer

LinkOut - more resources